VKTX financial statements
The full income statement, balance sheet, and cash-flow statement for Viking Therapeutics Inc. (VKTX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 393M+160.6% | 151M+49.7% | 101M+43.3% | 70.4M+26.4% | 55.7M+30.5% | ||
| Research & development | 345M+239.4% | 102M+59.3% | 63.8M+17.6% | 54.2M+20.6% | 45.0M+40.9% | |
| Selling, general & administrative | 48.4M-1.8% | 49.3M+33.1% | 37.0M+129.6% | 16.1M+50.6% | 10.7M-0.3% | |
| General & administrative | 48.4M-1.8% | 49.3M+33.1% | 37.0M+129.6% | 16.1M+50.6% | 10.7M-0.3% | |
| Operating income | -393M-160.6% | -151M-49.7% | -101M-43.3% | -70.4M-26.4% | -55.7M-30.5% | |
| Other non-operating income | 33.7M-17.7% | 41.0M+174.3% | 14.9M+903.5% | 1.49M+115.0% | 692K-78.1% | |
| Pre-tax income | -360M-227.1% | -110M-28.0% | -85.9M | — | — | |
| Income tax | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | 1.00K-50.0% | 2.00K | |
| Net income | -360M-227.1% | -110M-28.0% | -85.9M-24.7% | -68.9M-25.2% | -55.0M-39.2% | |
| -$3.19-215.8% | -$1.01-11.0% | -$0.91-1.1% | -$0.90-26.8% | -$0.71 | ||
| EPS (basic) | -$3.19-215.8% | -$1.01-11.0% | -$0.91-1.1% | -$0.90-26.8% | -$0.71 | |
| Weighted-avg shares (basic) | 113M+3.3% | 109M+15.6% | 94.3M+22.8% | 76.8M-0.5% | 77.2M | |
| Weighted-avg shares (diluted) | 113M+3.3% | 109M+15.6% | 94.3M+22.8% | 76.8M-0.5% | 77.2M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 716M-21.1% | 907M+147.0% | 367M+119.8% | 167M-20.7% | 211M-17.8% | ||
| Cash & equivalents | 166M+521.6% | 26.7M-51.9% | 55.5M+51.6% | 36.6M+38.9% | 26.4M-9.4% | |
| Prepaid expenses | 1.81M+60.1% | 1.13M-55.3% | 2.52M-26.1% | 3.41M+451.1% | 619K+40.0% | |
| 716M-21.2% | 908M+146.5% | 368M+118.7% | 169M-20.0% | 211M-17.9% | ||
| Operating lease right-of-use | 85.0K-91.5% | 1.00M-10.9% | 1.13M-20.6% | 1.42M+5572.0% | 25.0K-92.2% | |
| 76.7M+179.7% | 27.4M+43.3% | 19.1M-12.8% | 21.9M+150.0% | 8.78M-27.6% | ||
| Accounts payable | 53.3M+442.7% | 9.81M+30.6% | 7.51M-11.9% | 8.53M+490.7% | 1.44M-63.8% | |
| Current lease liability | 137K-72.0% | 489K+50.9% | 324K+6.6% | 304K+948.3% | 29.0K-91.2% | |
| 76.7M+173.4% | 28.0M+39.7% | 20.1M-13.5% | 23.2M+164.4% | 8.78M-27.8% | ||
| Non-current lease liability | 0.00-100.0% | 630K-32.7% | 936K-25.7% | 1.26M | — | |
| Operating lease liability (total) | 137K-87.8% | 1.12M-11.2% | 1.26M-19.4% | 1.56M+5293.1% | 29.0K-91.9% | |
| Total non-current liabilities | 0.00-100.0% | 630K-32.7% | 936K-25.7% | 1.26M | — | |
| 639M-27.4% | 880M+152.6% | 348M+139.8% | 145M-28.0% | 202M-17.4% | ||
| Common stock | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | |
| Additional paid-in capital | 1.49B+8.6% | 1.37B+86.6% | 734M+64.7% | 445M+4.6% | 426M+3.2% | |
| Retained earnings | -848M-73.7% | -488M-29.1% | -378M-29.4% | -292M-30.9% | -223M-32.7% | |
| Treasury stock | 0.00 | 0.00-100.0% | 6.79M+0.0% | 6.79M | — | |
| Total equity incl. non-controlling | 639M-27.4% | 880M+152.6% | 348M+139.8% | 145M-28.0% | 202M-17.4% | |
| Total liabilities & equity | 716M-21.2% | 908M+146.5% | 368M+118.7% | 169M-20.0% | 211M-17.9% | |
| Common shares issued | 115M+2.9% | 112M+11.4% | 100M+27.9% | 78.3M+0.0% | 78.2M+6.9% | |
| Common shares outstanding | 115M+2.9% | 112M+11.4% | 100M+27.9% | 78.3M+0.0% | 78.2M+6.9% | |
| Shares outstanding (cover) | 116M+2.9% | 112M+11.7% | 100M+28.1% | 78.4M+0.1% | 78.4M+5.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -279M-217.4% | -87.8M-19.6% | -73.4M-51.6% | -48.4M-1.7% | -47.6M-118.5% | ||
| Share-based compensation | 40.8M+37.4% | 29.7M+77.4% | 16.8M+93.1% | 8.67M+42.2% | 6.10M+4.8% | |
| Change in payables | 43.4M+1786.1% | 2.30M+326.2% | -1.02M-114.4% | 7.08M+378.5% | -2.54M-263.6% | |
| 341M+161.7% | -553M-209.0% | -179M-427.1% | 54.8M+44.2% | 38.0M-8.7% | ||
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 418M-62.5% | 1.11B+132.8% | 478M+293.9% | 121M-27.7% | 168M-40.1% | |
| Sales/maturities of investments | 759M+35.6% | 560M+87.2% | 299M+69.8% | 176M-14.5% | 206M-36.1% | |
| 76.4M-87.5% | 612M+125.7% | 271M+6418.8% | 4.16M-39.5% | 6.88M+624.2% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00-100.0% | 6.79M | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | — | — | — | 10.5M+483.1% | -2.75M-113.2% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.07B-10.0% | 4.52B+142.6% | 1.86B+158.2% | 721M+100.0% | 360M-13.6% | |
| P/B | 6.4×+24.0% | 5.1×+1.5% | 5.1×+6.1% | 4.8×+166.9% | 1.8×+4.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: VKTX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all VKTX filings on SEC EDGAR → Not investment advice.